Sitemap
- Home
- Company
- Quality
- News
- Immulite 2000 Analyzer
- Immunogenicity analysis and multiplex biomarker assays with new ECL equipment at Xendo
- Full clinical research services now offered
- Xendo's Bioanalysis and Drug Metabolism introduces new LIMS
- Disposables Reach Out to New Markets
- TI Pharma project on metabolic stability of NCE's takes off
- Xendo joins the Ride for the Roses
- Xendo CTM's director interviewed by C2W
- New Managing Director in Denmark
- The bisphosphonates bioanalytical challenge – Xendo’s answer: the risedronate case
- Focus Scandinavian activities
- Xendo CTM, a new life science company in The Netherlands
- Business Management services expanded
- Clinical pharmacology of chiral compounds – an expertise of Xendo
- GMP status van Nederlandse ziekenhuizen
- Xendo Newsletter special edition on bioanalysis and biomarkers - out now!
- Xendo conducts human microdosing (human phase 0) study for Biofrontera AG
- On-line clinical studies – LPS challenge testing
- On-line clinical studies – full integration of CPrU and bioanalysis
- Biotech News interview with Koos Koops and Ard Tijsterman
- Xendo partner in Top Institute Pharma
- Services
- GMP compliance
- Plant design and engineering
- Qualification and validation
- Calibration and plant maintenance
- Regulatory affairs
- Bioprocess development
- Clinical pharmacology unit
- Clinical research
- Bioanalysis and drug metabolism
- Clinical data management
- Medical writing
- Biometrics
- Pharmacokinetics and pharmacodynamics
- Drug development consultancy
- Business management
- Careers
- Contact
- Sitemap
- Search
- News
- Careers
